The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
Open accessAbstract
Introduction: Acute kidney injury following surgery incurs significant mortality with no proven preventative therapy. We investigated whether the α 2 adrenoceptor agonist dexmedetomidine (Dex) provides protection against ischemia-reperfusion induced kidney injury in vitro and in vivo. Methods: In vitro, a stabilised cell line of human kidney proximal tubular cells (HK2) was exposed to culture medium deprived of oxygen and glucose. Dex decreased HK2 cell death in a dose-dependent manner, an effect attenuated by the α 2 adrenoceptor antagonist atipamezole, and likely transduced by phosphatidylinositol 3-kinase (PI3K-Akt) signaling.In vivo C57BL/6J mice received Dex (25 μg/kg, intraperitoneal (i.p.)) 30 minutes before or after either bilateral renal pedicle clamping for 25 minutes or right renal pedicle clamping for 40 minutes and left nephrectomy. Results: Pre- or post-treatment with Dex provided cytoprotection, improved tubular architecture and function following renal ischemia. Consistent with this cytoprotection, dexmedetomidine reduced plasma high-mobility group protein B1 (HMGB-1) elevation when given prior to or after kidney ischemia-reperfusion; pretreatment also decreased toll-like receptor 4 (TLR4) expression in tubular cells. Dex treatment provided long-term functional renoprotection, and even increased survival following nephrectomy. Conclusions: Our data suggest that Dex likely activates cell survival signal pAKT via α 2 adrenoceptors to reduce cell death and HMGB1 release and subsequently inhibits TLR4 signaling to provide reno-protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions
Hall, J. E., Uhrich, T. D., Barney, J. A., Arain, S. R., & Ebert, T. J. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200003000-00035 · Cited by 1,069
Delayed graft function in kidney transplantation
Perico, N., Cattaneo, D., Sayegh, M. H., & Remuzzi, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17406-0 · Cited by 972
Dexmedetomidine: A Novel Sedative-Analgesic Agent
Gertler, R., Brown, H. C., Mitchell, D. H., & Silvius, E. N. (2001) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2001.11927725 · Cited by 856
TLR4 activation mediates kidney ischemia/reperfusion injury
Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F., & Chadban, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31008 · Cited by 836
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832
Cited by
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Weerink, M. A. S., Struys, M. M. R. F., Hannivoort, L. N., Barends, C. R. M., Absalom, A. R., & Colin, P. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0507-7 · Cited by 1,208
Renal ischemia/reperfusion injury; from pathophysiology to treatment.
Malek, M., & Nematbakhsh, M. (2015) · PubMed · doi:10.12861/jrip.2015.06 · Cited by 583
Wang, K., Wu, M., Xu, J., Wu, C., Zhang, B., Wang, G., & Ma, D. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.07.027 · Cited by 366
Self-citationPerioperative Dexmedetomidine Improves Outcomes of Cardiac Surgery
Ji, F., Li, Z., Nguyen, H., Young, N., Shi, P., Fleming, N., & Liu, H. (2013) · Circulation · doi:10.1161/circulationaha.112.000936 · Cited by 307
Renal ischemia/reperfusion injury: an insight on in vitro and in vivo models
Shiva, N., Sharma, N., Kulkarni, Y. A., Mulay, S. R., & Gaikwad, A. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117860 · Cited by 177
Metadata
- Authors
- Gu, J., Sun, P., Zhao, H., Watts, H. R., Sanders, R. D., Terrando, N., Xia, P., Maze, M., & Ma, D.
- Venue
- Critical Care
- Published
- 2011-06-24
- Volume
- 15
- Issue
- 3
- Pages
- R153-R153
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2123024844
- Cited by
- 276
- References
- 35
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. https://app.cochat.ai/papers/10.1186/cc10283
- The paper
- Gu, J., Sun, P., Zhao, H., Watts, H. R., Sanders, R. D., Terrando, N., Xia, P., Maze, M., & Ma, D. (2011). Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Critical Care. https://doi.org/10.1186/cc10283
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.